This portal is a central location to log new product ideas or enhancement requests for the HealthSource application. The information submitted on this portal will be reviewed and evaluated by Product Management to determine the cost/benefit of the request, assess the priority of the request, and determine if the request should be placed within a product backlog or roadmap.
Adderoll is a medication that is used to treat attention deficit hyperactivity disorder (ADHD). It is a central nervous system stimulant that increases the levels of dopamine and norepinephrine in the brain. Adderoll is a Schedule II controlled substance in the United States and Canada and a Schedule III controlled substance in the United Kingdom.